BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 11485341)

  • 1. Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis.
    Woo T; Adachi JD
    Best Pract Res Clin Rheumatol; 2001 Jul; 15(3):469-81. PubMed ID: 11485341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis.
    Hodsman A; Adachi J; Olszynski W
    CMAJ; 1996 Oct; 155(7):945-8. PubMed ID: 8837544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.
    Siminoski K; Josse RG
    CMAJ; 1996 Oct; 155(7):962-5. PubMed ID: 8837547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women. A review.
    Martens MG
    J Reprod Med; 2003 Jun; 48(6):425-34. PubMed ID: 12856513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy.
    Miller PD
    Clin Ther; 2005 Apr; 27(4):361-76. PubMed ID: 15922811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of osteoporosis: current data and prospects].
    Reginster JY; Deroisy R; Franchimont P
    Rev Rhum Ed Fr; 1994 Dec; 61(10 Pt 2):155S-164S. PubMed ID: 7858567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
    Uebelhart D; Frey D; Frey-Rindova P; Goerres G; Michel BA
    Z Rheumatol; 2003 Dec; 62(6):512-7. PubMed ID: 14685711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone diseases with Pain. Osteoporosis].
    Hayashi Y
    Clin Calcium; 2007 Apr; 17(4):606-12. PubMed ID: 17404492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.
    Buckley LM; Hillner BE
    J Rheumatol; 2003 Jan; 30(1):132-8. PubMed ID: 12508402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis: strategies for prevention and management.
    Keen R
    Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):109-22. PubMed ID: 17350547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of osteoporosis due to ovarian failure.
    Eastell R
    Med Pediatr Oncol; 2003 Sep; 41(3):222-7. PubMed ID: 12868123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture.
    Seeman E; Eisman JA
    Med J Aust; 2004 Mar; 180(6):298-303. PubMed ID: 15012571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials with bisphosphonates.
    Lombardi A; Santora AC
    Ann Ital Med Int; 1992; 7(3 Suppl):158S-165S. PubMed ID: 1297394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bisphosphonates].
    Matsumoto T
    Clin Calcium; 2004 Jan; 14(1):145-52. PubMed ID: 15576971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of osteoporosis: where are we and where are we going to.
    Reginster JY
    Morphologie; 1999 Jun; 83(261):41-5. PubMed ID: 10546235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
    Epstein S
    Clin Ther; 2006 Feb; 28(2):151-73. PubMed ID: 16678639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.
    Inderjeeth CA; Foo AC; Lai MM; Glendenning P
    Bone; 2009 May; 44(5):744-51. PubMed ID: 19130909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.